rs4732513
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs4732513(C;C) |
Make rs4732513(C;T) |
Make rs4732513(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 7 |
Position | 75978290 |
Gene | POR |
is a | snp |
is | mentioned by |
dbSNP | rs4732513 |
dbSNP (classic) | rs4732513 |
ClinGen | rs4732513 |
ebi | rs4732513 |
HLI | rs4732513 |
Exac | rs4732513 |
Gnomad | rs4732513 |
Varsome | rs4732513 |
LitVar | rs4732513 |
Map | rs4732513 |
PheGenI | rs4732513 |
Biobank | rs4732513 |
1000 genomes | rs4732513 |
hgdp | rs4732513 |
ensembl | rs4732513 |
geneview | rs4732513 |
scholar | rs4732513 |
rs4732513 | |
pharmgkb | rs4732513 |
gwascentral | rs4732513 |
openSNP | rs4732513 |
23andMe | rs4732513 |
SNPshot | rs4732513 |
SNPdbe | rs4732513 |
MSV3d | rs4732513 |
GWAS Ctlg | rs4732513 |
GMAF | 0.4688 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
[PMID 24273552] A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor